Imaginis.com was selected as a winner in the Spring/Summer 2007 World Wide Web Health Awards. This program recognizes the best health information Web sites for consumers and professionals, as is coordinated by the Health Information Resource Center, a national clearinghouse for consumer health information programs and materials.

Researchers of a large breast cancer study of sisters are encouraging more minority women to enroll to ensure a diverse study sample and far-reaching results. The National Institute of Environmental Health Sciences plans to enroll 50,000 women in its Sister Study by the end of 2007. The study's purpose is to study breast cancer risk factors in sisters of women diagnosed with breast cancer. As of early August 2007, over 39,000 women had enrolled in the study, 12% of whom represent minorities.

Researchers are studying whether a vaccine similar to one being developed for prostate cancer would help treat breast cancer. The vaccine, called Neuvenge, is designed to target certain types of breast cancer cells in women whose cancers have spread to other organs despite treatment. The first phase of the study included a small number of women but showed that the vaccine appears safe enough to warrant further study.

According to the American Cancer Society, the chance that breast cancer will be responsible for a woman's death is about 1 in 33 (3%). The incidence rate of breast cancer (number of new breast cancers per 100,000 women) increased by approximately 4% during the 1980s but leveled off to 100.6 cases per 100,000 women in the 1990s. The death rates from breast cancer also declined significantly between 1992 and 1996, with the largest decreases among younger women. Medical experts attribute the decline in breast cancer deaths to earlier detection and more effective treatments.